Literature DB >> 8730132

Lack of association between thyroid status and chondrocalcinosis or osteoarthritis: the Framingham Osteoarthritis Study.

C E Chaisson1, T E McAlindon, D T Felson, A Naimark, P W Wilson, C T Sawin.   

Abstract

OBJECTIVE: To assess whether current thyroid status is associated with chondrocalcinosis or osteoarthritis (OA), we examined the cross sectional association of serum thyrotropin (thyroid stimulating hormone, TSH) with chondrocalcinosis and with knee OA in members of the Framingham OA study.
METHODS: Knee radiographs were taken at the 18th biennial examination (1983-85) and measurement of serum TSH at either the 15th (1977-79) or the 18th biennial examination. Chondrocalcinosis was dichotomized as absent or present and knee OA was based on a Kellgren and Lawrence score of grade 2 or greater in either knee. Thyroid status was determined by serum TSH concentration classed into clinically relevant categories: < or = 0.1 mU/l(low); > 0.1 < 0.4 mU/l (slightly low); 0.4 to 5.0 mU/l (normal); > 5 < or = 10 mU/l (slightly high); and > 10 mU/l (high).
RESULTS: Data were collected on 577 men and 798 women. We found no association between elevated serum TSH concentration and chondrocalcinosis. Our results, though not statistically significant, suggest an inverse relation, with an odds ratio (OR) of 0.41 (95% CI 0.10, 1.73) for those subjects. in the highest TSH group and 1.79 (95% CI 0.39, 8.24) for those in the lowest TSH group, compared to subjects in the normal range. We found no association between serum TSH concentration and radiographic knee OA, with an OR of 0.85 (95% CI 0.47, 1.51) for those in the highest serum TSH group and 1.51 (95 CI 0.54, 4.22) for those in the lowest TSH group, compared to the normal group. Exclusion of subjects taking thyroid hormone confirmed these null results.
CONCLUSION: There was no evidence, in a large unselected population of older persons, of a significant association between current thyroid status and either chondrocalcinosis or OA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730132

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  5 in total

Review 1.  Clinical trials review: crystal deposition diseases.

Authors:  R A Terkeltaub
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

2.  Association between sensitivity to thyroid hormone indices and the risk of osteoarthritis: an NHANES study.

Authors:  Shuai Chen; Xiaohe Sun; Guowei Zhou; Jie Jin; Zhiwei Li
Journal:  Eur J Med Res       Date:  2022-07-11       Impact factor: 4.981

3.  Monoarticular hip involvement in pseudogout.

Authors:  Figen Kocyigit; Ersin Kuyucu; Ali Kocyigit
Journal:  Case Rep Rheumatol       Date:  2015-03-09

4.  Incidence of total hip or knee replacement due to osteoarthritis in relation to thyroid function: a prospective cohort study (The Nord-Trøndelag Health Study).

Authors:  Alf Inge Hellevik; Marianne Bakke Johnsen; Arnulf Langhammer; Anne Marie Fenstad; Ove Furnes; Kjersti Storheim; John Anker Zwart; Gunnar Flugsrud; Lars Nordsletten
Journal:  BMC Musculoskelet Disord       Date:  2017-05-18       Impact factor: 2.362

5.  Association of anti-thyroid antibodies with radiographic knee osteoarthritis and chondrocalcinosis: a NHANES III study.

Authors:  Clement E Tagoe; Wanyi Wang; Shudan Wang; Kamil E Barbour
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-08-04       Impact factor: 5.346

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.